The LEQVIO® Service Center can
assist you at any point during your
patient's journey.

Clipboard and pen icon


Register for the Service Center Portal and submit your request online.

Visit Service Center Portal


Simply download the one-page Start Form and fax it to 877-LEQVIO8 877-LEQVIO8 (877-537-8468)(877-537-8468).

Download Start Form
Magnifying glass icon


The Service Center will verify benefits to determine patient coverage requirements. New patients with
commercial insurance may be eligible to receive two free doses of LEQVIO if coverage is delayed or denied.
Limitations apply.*

Visit Patient
coverage types
Connect with a
dedicated Specialist
Co-pay card icon


Eligible commercially insured patients can enroll in the LEQVIO Co-pay Program and may pay as little as $0
for each LEQVIO treatment. Subject to terms and conditions. Limitations apply.

Visit Affordability
Open box icon


We're here to help no matter what product acquisition method you
choose—buy-and-bill, referral to an alternate injection/infusion center, or specialty pharmacy.

View Acquisition Visit alternate injection/infusion center locator
Hand with dollar sign icon


After LEQVIO is acquired and administered, the Service Center can support you through the claim submission process.

Visit Billing and coding
Headset with heart icon


A dedicated Specialist is on standby, ready to connect and answer your questions. With the LEQVIO Care Program, patients have access to medication reminders, healthy living tips and tools, as well as a dedicated Patient Care Specialist. In addition, we offer Next Dose Support for your office, to ensure any coverage-related requirements are addressed in advance of your patient's next appointment.

Contact us to
learn more

eServices coming soon!

Electronic services for benefits
verification and prior
authorization research will be
available in the coming months.

To select a specific service,
visit our portal:
Service Center Portal

*Bridge to Commercial Program Terms & Conditions: Eligible patients must have commercial insurance, a valid prescription for LEQVIO, and a prior authorization that has been denied or pending for greater than 3 calendar days. Program provides up to two (2) doses of free medication. Program is not available to patients who are uninsured or whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program, or where prohibited by law. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Other limitations may apply. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.

Limitations apply. Valid only for those with commercial insurance. The Program may include the Co-pay Card, Payment Card (if applicable), and Rebate. Per treatment maximums and an annual benefit cap apply. For patients covered under the medical benefit, rebate for out-of-pocket costs will be assigned directly to provider, unless patient requests direct reimbursement. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient's insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient's insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.



Up Arrow Down Arrow

Adverse reactions in clinical trials (≥3% of patients treated with LEQVIO® and more frequently than placebo) were injection site reaction, arthralgia, urinary tract infection, diarrhea, bronchitis, pain in extremity and dyspnea.

Adverse reactions led to discontinuation in 2.5% and 1.9% of LEQVIO- and placebo-treated patients, respectively. Discontinuation due to injection site reactions, which included injection site pain, erythema and rash, were 0.2% and 0% of LEQVIO- and placebo-treated patients, respectively.

Please click here for LEQVIO full Prescribing Information.


LEQVIO (inclisiran) injection is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with clinical atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) who require additional lowering of low-density lipoprotein cholesterol (LDL-C). Limitations of Use: The effect of LEQVIO on cardiovascular morbidity and mortality has not been determined.

Please click here for LEQVIO full Prescribing Information.